However, a minor fraction of RAB GTPases are proposed to serve as tumor suppressors, and posttranslational modifications may affect their GTPase activity (Tzeng and Wang, 2016; Jin et al., 2021). The gene discussed is RAB6A; the disease is neoplasm.